** Shares of SomnoMed Ltd SOM.AX fall 12.3% to A$0.465, their lowest levels since January 20
** The medical device maker plans to absorb the costs associated with the tariff changes in the immediate term and reiterates FY25 outlook for revenue and EBITDA
** Co imports its products to the U.S. and manufactures them primarily in the Philippines
** Stock posts biggest percentage drop since December 16
** Stock sees busiest session since early February
** Stock up 1.1% YTD, including moves in current session
(Reporting by Jasmeen Ara Shaikh in Bengaluru)
((JasmeenAraIslam.Shaikh@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.